Claudin-3 and claudin-4 are highly overexpressed in ovarian cancer including serous carcinoma compared to normal ovarian tissues, and their expression is also upregulated in several other malignancies, including breast, gastric, pancreatic, prostate and uterine cancers (Table 2). The gene discussed is CLDN4; the disease is ovarian carcinoma.